338 related articles for article (PubMed ID: 9916932)
1. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis.
Yang Y; Jeanpierre C; Dressler GR; Lacoste M; Niaudet P; Gubler MC
Am J Pathol; 1999 Jan; 154(1):181-92. PubMed ID: 9916932
[TBL] [Abstract][Full Text] [Related]
2. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
3. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
[TBL] [Abstract][Full Text] [Related]
4. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
5. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S; Niaudet P; Gubler MC; Grünfeld JP; Jaubert F; Kuttenn F; Fékété CN; Souleyreau-Therville N; Thibaud E; Fellous M; McElreavey K
Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
7. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
8. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
9. Embryonal hyperplasia of Bowman's capsular epithelium in patients with WT1 mutations.
Fukuzawa R; Eccles MR; Ikeda M; Hata J
Pediatr Nephrol; 2003 Jan; 18(1):9-13. PubMed ID: 12488983
[TBL] [Abstract][Full Text] [Related]
10. WT1 and glomerular diseases.
Niaudet P; Gubler MC
Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
[TBL] [Abstract][Full Text] [Related]
11. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis.
Ohtaka A; Ootaka T; Sato H; Soma J; Sato T; Saito T; Ito S
Am J Kidney Dis; 2002 Mar; 39(3):475-85. PubMed ID: 11877566
[TBL] [Abstract][Full Text] [Related]
12. Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.
Schumacher VA; Jeruschke S; Eitner F; Becker JU; Pitschke G; Ince Y; Miner JH; Leuschner I; Engers R; Everding AS; Bulla M; Royer-Pokora B
J Am Soc Nephrol; 2007 Mar; 18(3):719-29. PubMed ID: 17267748
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of podocyte phenotype in idiopathic collapsing glomerulopathy and HIV-associated nephropathy.
Yang Y; Gubler MC; Beaufils H
Nephron; 2002 Jul; 91(3):416-23. PubMed ID: 12119471
[TBL] [Abstract][Full Text] [Related]
14. Glomerular epithelial cell phenotype in diffuse mesangial sclerosis: a report of 2 cases with markedly increased urinary podocyte excretion.
Ikezumi Y; Suzuki T; Karasawa T; Kaneko U; Yamada T; Hasegawa H; Nagata M; Saitoh A
Hum Pathol; 2014 Aug; 45(8):1778-83. PubMed ID: 24856573
[TBL] [Abstract][Full Text] [Related]
15. Diaphragmatic hernia in Denys-Drash syndrome.
Devriendt K; Deloof E; Moerman P; Legius E; Vanhole C; de Zegher F; Proesmans W; Devlieger H
Am J Med Genet; 1995 May; 57(1):97-101. PubMed ID: 7645607
[TBL] [Abstract][Full Text] [Related]
16. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
Klamt B; Koziell A; Poulat F; Wieacker P; Scambler P; Berta P; Gessler M
Hum Mol Genet; 1998 Apr; 7(4):709-14. PubMed ID: 9499425
[TBL] [Abstract][Full Text] [Related]
17. [A genetic childhood disease with consequences in adult life: the Denys-Drash syndrome].
Löwik MM; van den Berkmortel FW; Noordam C; van Hamersvelt HW; van den Heuvel LP; Levtchenko EN
Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1751-5. PubMed ID: 16114294
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?
Ohtaka A; Ootaka T; Sato H; Ito S
Nephrol Dial Transplant; 2002; 17 Suppl 9():11-5. PubMed ID: 12386275
[TBL] [Abstract][Full Text] [Related]
19. Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene.
Ito S; Takata A; Hataya H; Ikeda M; Kikuchi H; Hata J; Honda M
J Pediatr; 2001 Mar; 138(3):425-7. PubMed ID: 11241056
[TBL] [Abstract][Full Text] [Related]
20. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes.
Ratelade J; Arrondel C; Hamard G; Garbay S; Harvey S; Biebuyck N; Schulz H; Hastie N; Pontoglio M; Gubler MC; Antignac C; Heidet L
Hum Mol Genet; 2010 Jan; 19(1):1-15. PubMed ID: 19797313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
